(c) 2024 PillSync.com

Metolazone 10 MG Oral Tablet

INDICATIONS AND USAGE Metolazone is indicated for the treatment of salt and water retention including: • edema accompanying congestive heart failure; • edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. Metolazone is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. Mykrox ® tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. A dose titration is necessary if Mykrox ® tablets are to be substituted for Zaroxolyn ® tablets and other formulations of metolazone that share its slow and incomplete bioavailability, in the treatment of hypertension. Usage In Pregnancy The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy and there is no evidence that they are useful in the treatment of developed toxemia. Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequence of pregnancy. Metolazone is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (see PRECAUTIONS ). Dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. There is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema, in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances, this edema may cause extreme discomfort which is not relieved by rest. In these cases, a short course of diuretics may be appropriate.

Eon Labs, Inc.


4 years ago OVAL YELLOW E56 Metolazone 10 MG Oral Tablet

OVAL YELLOW E56

HOW SUPPLIED

METOLAZONE tablets, USP for oral administration are available as: 2.5 mg: pink, shallow biconvex, modified oval tablets, debossed “ E 50” on one side, plain on the other side and supplied as: NDC 0185-5050-01 bottles of 100 NDC 0185-5050-10 bottles of 1000 5 mg: blue, shallow biconvex, modified oval tablets, debossed “ E 55” on one side, plain on the other side and supplied as: NDC 0185-0055-01 bottles of 100 NDC 0185-0055-10 bottles of 1000 10 mg: yellow, shallow biconvex, modified oval tablets, debossed “ E 56” on one side, plain on the other side and supplied as: NDC 0185-5600-01 bottles of 100 NDC 0185-5600-10 bottles of 1000 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep out of the reach of children. Zaroxolyn ® and Mykrox ® are registered trademarks of UCB Manufacturing, Inc., Rochester, NY 14623. Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540 46316475 Rev. September 2022


More pills like OVAL E56

Related Pills

quetiapine 300 mg

aurobindo pharma limited

amlodipine 5 mg

epic pharma, llc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site